BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19153651)

  • 1. Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?
    Dahlbäck B; Nielsen LB
    Cell Mol Life Sci; 2009 Feb; 66(4):559-64. PubMed ID: 19153651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
    Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
    Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
    Christoffersen C; Ahnström J; Axler O; Christensen EI; Dahlbäck B; Nielsen LB
    J Biol Chem; 2008 Jul; 283(27):18765-72. PubMed ID: 18460466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein M: progress in understanding its regulation and metabolic functions.
    Christoffersen C; Dahlbäck B; Nielsen LB
    Scand J Clin Lab Invest; 2006; 66(7):631-7. PubMed ID: 17101555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
    Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB
    J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
    Elsøe S; Ahnström J; Christoffersen C; Hoofnagle AN; Plomgaard P; Heinecke JW; Binder CJ; Björkbacka H; Dahlbäck B; Nielsen LB
    Atherosclerosis; 2012 Mar; 221(1):91-7. PubMed ID: 22204862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
    Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
    Elsøe S; Christoffersen C; Luchoomun J; Turner S; Nielsen LB
    Biochim Biophys Acta; 2013 Jul; 1831(7):1287-92. PubMed ID: 24046869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of human apolipoprotein M-containing lipoproteins.
    Christoffersen C; Nielsen LB; Axler O; Andersson A; Johnsen AH; Dahlbäck B
    J Lipid Res; 2006 Aug; 47(8):1833-43. PubMed ID: 16682745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M.
    Ahnström J; Faber K; Axler O; Dahlbäck B
    J Lipid Res; 2007 Aug; 48(8):1754-62. PubMed ID: 17525477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human apolipoprotein (apoM).
    Xu N; Dahlbäck B
    J Biol Chem; 1999 Oct; 274(44):31286-90. PubMed ID: 10531326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.
    Sevvana M; Ahnström J; Egerer-Sieber C; Lange HA; Dahlbäck B; Muller YA
    J Mol Biol; 2009 Nov; 393(4):920-36. PubMed ID: 19733574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
    Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoM: gene regulation and effects on HDL metabolism.
    Nielsen LB; Christoffersen C; Ahnström J; Dahlbäck B
    Trends Endocrinol Metab; 2009 Mar; 20(2):66-71. PubMed ID: 19200746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
    Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
    J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.
    Ahnström J; Axler O; Jauhiainen M; Salomaa V; Havulinna AS; Ehnholm C; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlbäck B
    J Lipid Res; 2008 Sep; 49(9):1912-7. PubMed ID: 18490703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of apoM in normal and genetically modified mice.
    Faber K; Axler O; Dahlbäck B; Nielsen LB
    J Lipid Res; 2004 Jul; 45(7):1272-8. PubMed ID: 15102887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
    Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.